Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome
- PMID: 19488615
- PMCID: PMC2694253
- DOI: 10.1590/s1807-59322009000500016
Systemic inflammatory response syndrome and multiple organ dysfunction in patients with acute tumor lysis syndrome
References
-
- Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. Am J Med. 2004;116:546–54. - PubMed
-
- Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3–11. - PubMed
-
- Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644–55. - PubMed
-
- Hijiya N, Metzger ML, Pounds S, Schmidt JE, Razzouk BI, Rubnitz JE, et al. Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer. 2005;44:63–9. - PubMed
-
- Soares M, Salluh JI. Validation of the SAPS 3 admission prognostic model in patients with cancer in need of intensive care. Intensive Care Med. 2006;32:1839–44. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
